Acetazolamide in the treatment of seizures

Annals of Pharmacotherapy

Volumn 30, Issue 5, 1996, Pages 514-518

  Reiss, William G ^a   Oles, Karen S ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR;

ADULT; ALLERGIC REACTION; BLOOD DYSCRASIA; CHILD; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENZYME INHIBITION; FEMALE; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; REVIEW; SEIZURE; TERATOGENESIS;

ACETAZOLAMIDE; ADULT; ANTICONVULSANTS; CHILD; DRUG INTERACTIONS; EPILEPSY; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION;

EID: 0029965708     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000515     Document Type: Article

References (68)

1. Carter MJ. Carbonic anhydrase: isoenzymes, properties, distribution, and functional significance, Biol Rev 1972;47:465-513
2. Millichap JG, Woodbury DM, Goodman LS. Mechanism of the anticonvulsant action of acetazolamide, a carbonic anhydrase inhibitor. J Pharmacol Exp Ther 1955;115:251.
3. Woodbury DM, Kemp JW. Other antiepileptic drugs. Sulfonamides and derivatives- acetazolamide. In: Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK, eds. Antiepileptic drugs. 3rd ed. New York: Raven Press, 1989:855-75.
4. Woodbury DM, Esplin DW. Neuropharmacology and neurochemistry of anticonvulsant drugs. Proc Assoc Res Nerv Ment Dis 1969;37:24-56.
5. Anderson RE, Chiu P, Woodbury DM. Mechanisms of tolerance to the anticonvulsant effects of acetazolamide in mice: relation to the activity and amount of carbonic anhydrase in brain. Epilepsia 1989;30:208-16.
6. Bergstrom WH, Garzoli RF, Lombroso C, Davidson DT, Wallace WM. Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics. Am J Dis Child 1952;84:71-3.
7. Ansell B, Clarke E Acetazolamide in treatment of epilepsy. Br Med J 1956;1:650-61.
8. Golla FL, Hodge RS. Control of petit mal by acetazolamide. J Ment Sci 1957;103:214-7.
9. Lombroso CT, Davidson DT Jr, Gross-Bianchi ML. Further evaluation of acetazolamide (Diamox) in treatment of epilepsy. JAMA 1956;160:268-72.
10. Oles KS, Penry JK, Cole DLW, Howard G. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989;30:74-8.
11. Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol 1981;23:761-9.
12. Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy Neurology 1990;40:1677-81.
13. Vaamonde J, Legarda I, Jimenez-Jimenez J, Obeso JA Acetazolamide improves action myoclonus in Ramsay Hunt syndrome. Clin Neuropharmacol 1992;15:392-6.
14. Goetting MG. Catamenial exacerbation of action myoclonus. Successful treatment with acetazolamide. J Neurol Neurosurg Psychiatry 1985;48:1304-5.
15. Lancman ME, Asconape JJ, Walker F. Acetazolamide appears effective in the management of valproate-induced tremor. Move Disord 1994;9:369.
16. Maren TH, Mayer E, Wadsworth BC. Carbonic anhydrase inhibition. I. The pharmacology of Diamox (2-acetylamino-1,2,4-thiadiazole-5-sulfonamide). Bull Johns Hopkins Hosp 1954;95:199-243.
17. Maren TH, Robinson B. The pharmacology of acetazolamide as related to cerebrospinal fluid and the treatment of hydrocephalus. Bull Johns Hopkins Hosp 1960;106:1-24.
18. Yakatan GJ, Frome EL, Leonard RG, Shah AC, Doluisio JT Bioavailability of acetazolamide tablets. J Pharm Sci 1978;67:252-6.
19. Ellis PP, Price PK, Kelmenson R, Rendi MA. Effectiveness of generic acetazolamide. Arch Ophthalmol 1982;100:1920-2.
20. Berson FG, Epstein DL, Grant WM, Hutchinson BT, Dobbs PC. Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol 1980;98:1051-4.
21. Joyce PW, Mills KB, Richardson T, Mawer GE. Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma. Br J Clin Pharmacol 1989;27:597-606.
22. Carbonic anhydrase inhibitors, systemic. In. The United States pharmacopeia drug information (USP DI). Drug information for the health care professional. 14th ed. Rockville, MD: United States Pharmacopeial Convention, Inc., 1994:732.
23. Chapron DJ, Sweeney KR, Feig PU, Kramer PA. Influence of age on the disposition of acetazolamide. Br J Clin Pharmacol 1985;19:363-71.
24. Kunka RL, Mattocks AM. Relationship of pharmacokinetics to pharmacological response for acetazolamide. J Pharm Sci 1979;68:347-9
25. Schwenk MH, Blaustein DA, Wagner JD. The pharmacokinetics of acetazolamide during CAPD. Adv Perit Dial 1994;10:44-6.
26. Roy LF, Dufresne LR, Legault L, Long H, Morin C. Acetazolamide in hemodialysis patients: a rational use after ocular surgery. Am J Kidney Dis 1992;20:650-2.
27. Watson WA, Garrelts JC, Zinn PD, Garriott JC, McLemore L, Clementi WA. Chronic acetazolamide intoxication. Clin Toxicol 1985;22:549-63.
28. Inui M, Azuma H, Nishimura T, Hatada N. The concentration of acetazolamide in blood and saliva. In: Akimoto H, Kazamatsuri H, Seino M, Ward AA Jr, eds. Advances in epileptology. The XIIIth Epilepsy International Symposium. New York: Raven Press, 1982;13:307-9.
29. McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974;189:191-201.
30. Peralta J, Abelairas J, Fernandez-Guardiola J. Anaphylactic shock and death after oral intake of acetazolamide (letter). Am J Ophthalmol 1992;114:367.
31. Stock JG Sulfonamide hypersensitivity and acetazolamide. Arch Ophthalmol 1990;108:634-5
32. Tawil R, Moxley RT III, Griggs RC. Acetazolamide-induced nephrolithiasis. implications for treatment of neuromuscular disorders. Neurology 1993;43:1105-6
33. Bearn PE. Disappearance of staghorn calculi following withdrawal of treatment with acetazolamide. Br J Urol 1989;63:329.
34. Higashihara E, Nutahara K, Takeuchi T, Shoji N, Araie M, Aso Y. Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate. J Urol 1991;145:942-8.
35. Reisner EH, Morgan MC. Thrombocytopenia following acetazolamide (Diamox) therapy. JAMA 1956;160:206-7.
36. Underwood LC. Fatal bone marrow depression after treatment with acetazolamide (Diamox). JAMA 1956;161:1477-8
37. Keisu M, Wiholm BE, Ost A, Mortimer O. Acetazolamide-associated aplastic anaemia. J Intern Med 1990;228:627-32.
38. Shapiro S, Fraunfelder FT. Acetazolamide and aplastic anemia Am J Ophthalmol 1992;113:328-30.
39. McWhae JA, Chang J, Lipton JH. Drug-induced fatal aplastic anemia following cataract surgery. Can J Ophthalmol 1992;27:313-5.
40. Hall TJ, Higgins W, Tardif C, Chambers TJ. A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II. Calcif Tissue Int 1991;49:328-32.
41. Pierce WM Jr, Nardin GF, Fuqua MF, Sabah-Maren E, Stem SH. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 1991;6:347-54.
42. Gram J, Bollerslev J, Nielsen HK, Larsen HF, Mosekilde L. The effect of carbonic anhydrase inhibition on calcium and bone homeostasis in healthy postmenopausal women. J Intern Med 1990;228:364-71.
43. Mallette LE. Acetazolamide-accelerated anticonvulsant osteomalacia. Arch Intern Med 1977;137:1013-7.
44. Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osleopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 1985;313:139-45.
45. Brechue WF, Stager JM, Lukaski HC. Body water and electrolyte responses to acetazolamide in humans. J Appl Physiol 1990;69:1397-401.
46. Chapron DJ, Gomolin IH, Sweeney KR. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J Clin Pharmacol 1989;29:348-53.
47. Heller I, Halevy J, Cohen S, Theodor E. Significant metabolic acidosis induced by acetazolamide. Arch Intern Med 1985;145:1815-7.
48. Epstein DL, Grant WM Carbonic anhydrase inhibitor side effects. Arch Ophthalmol 1977;95:1378-82.
49. Arrigg CA, Epstein DL, Giovanoni R, Grant WM. The influence of supplemental sodium acetate on carbonic anhydrase inhibitor-induced side effects. Arch Ophthalmol 1981;99:1969-72.
50. Mitchell JH, Singer MM, Johnson RL Jr. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1972;1:375-89.
51. Littlewood R, Harriott J, Cooper R, Brine P. Acetazolamide and general anaesthesia (letter). Med J Aust 1984;141:550.
52. Stager JM, Tucker A, Cordain L, Engerbretson BJ, Brechue WF, Matulich CC Normoxic and hypoxic exercise tolerance in man following carbonic anhydrase inhibition with acetazolamide. Med Sci Sports Exerc 1990;22:178-84.
53. Masuyama S, Hirata K, Saito A. Ondine's curses: side effect of acetazolamide (letter)? Am J Med 1989;86:637.
54. Miller LG, Miller SM. Altered taste secondary to acetazolamide therapy. J Fam Pract 1990;31:199-200.
55. Shah P, O'Donnell B, Pochkhanawala F, Tan CY. Severe exacerbation of rosacea by oral acetazolamide. Br J Dermatol 1993;129:647-8.
56. Weiss IS. Hirsutism after chronic administration of acetazolamide. Am J Ophthalmol 1974;78:327.
57. Wallace TR, Fraunfelder FT, Petursson GJ, Epstein DL. Decreased libido - a side effect of carbonic anhydrase inhibitor. Ann Ophthalmol 1979;11:1563-6.
58. Syversen GB, Morgan JP, Weintraub M, Myers GJ. Acetazolamide-induced interference with primidone absorption. Arch Neurol 1977;34:80-4.
59. Sweeney KR, Chapron DJ, Brandt JL, Gomolin IH, Feig PU, Kramer PA. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation Clin Pharmacol Ther 1986;40:518-24
60. Rousseau P, Fuentevilla-Clifton A. Acetazolamide and salicylate interaction in the elderly: a case report. J Am Geriatr Soc 1993;41:868-9.
61. Keogh A, Esmore D, Spratt P, Sandic E, McCluskey P. Acetazolamide and cyclosporine. Transplantation 1988;46:478-9.
62. Gerhardt RE, Knouss RF, Thyrum PT, Luchi RJ, Morris JJ Jr. Quinidine excretion in aciduria and alkaluria Ann Intern Med 1969;71:927-33.
63. Thomsen K, Schou M. Renal lithium excretion in man. Am J Physiol 1968;215:823-7.
64. Robinson CA, Dobbs J. Acetazolamide interference with theophylline analysis by high performance liquid chromatography. Clin Chem 1978;24:2208-9.
65. Maren TH. Teratology and carbonic anhydrase inhibition. Arch Ophthalmol 1971;85:1-2
66. Worsham GF, Beckman EN, Mitchell EH. Sacrococcygeal teratoma in a neonate. JAMA 1978;240:251-2.
67. Merlob P, Litwin A, Mor N. Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn. Eur J Obstet Gynecol Reprod Biol 1990;35:85-8.
68. Soderman P, Hartwig P, Fagerlund C. Acetazolamide excretion into human breast milk. Br J Clin Pharmacol 1984;17:599-600.